Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GPT HealthcareNSE:GPTHEALTH +1.59%45 3-1 Month Momentum % is 4.34% as of Sep. 21, 2026. GuruFocus rates NSE:GPTHEALTH with a GF Score™ of 45/100. The stock has 4 warning signs investors should review. Among 670 Healthcare Providers & Services companies, GPT Healthcare ranks better than 59.85% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-21), GPT Healthcare's 3-1 Month Momentum % is 4.34%.
The industry rank for GPT Healthcare's 3-1 Month Momentum % or its related term are showing as below:
NSE:GPTHEALTH's 3-1 Month Momentum % is ranked better than 59.85% of 670
companies
in the Healthcare Providers & Services industry
Industry Median: 0.61
vs NSE:GPTHEALTH: 4.34
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
GPT Healthcare 3-1 Month Momentum % Related Terms
NSE:GPTHEALTH vs HCA, THC, EHC: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, GPT Healthcare's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GPT Healthcare 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GPT Healthcare's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where GPT Healthcare's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GPT Healthcare (NSE:GPTHEALTH) has a 3-1 Month Momentum % of 4.34% as of Sep. 21, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on GPT Healthcare and its competitors. According to the industry distribution chart, GPT Healthcare ranks #269 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 40.1%.
Is GPT Healthcare's 3-1 Month Momentum % too high?
GPT Healthcare's current 3-1 Month Momentum % is 4.34%. The Healthcare Providers & Services industry median 3-1 Month Momentum % is 0.61. GPT Healthcare's value of 4.34% is 611.5% above this industry median. Based on the distribution chart, GPT Healthcare ranks #269 out of 670 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, GPT Healthcare has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does GPT Healthcare's 3-1 Month Momentum % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, GPT Healthcare ranks #269 out of 670 companies for 3-1 Month Momentum %. This puts GPT Healthcare in the upper half of its industry. The industry median 3-1 Month Momentum % is 0.61. GPT Healthcare's value of 4.34% is 611.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
The median 3-1 Month Momentum % among Healthcare Providers & Services companies is 0.61, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GPT Healthcare's current 3-1 Month Momentum % of 4.34% is 611.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on GPT Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 3-1 Month Momentum % is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GPT Healthcare's current 3-1 Month Momentum % is 4.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GPT Healthcare stock overvalued right now?
GPT Healthcare (NSE:GPTHEALTH) has a current 3-1 Month Momentum % of 4.34%. The current 3-1 Month Momentum % is 4.34% and 611.5% above the Healthcare Providers & Services industry median of 0.61. GPT Healthcare's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For GPT Healthcare (NSE:GPTHEALTH), the current 3-1 Month Momentum % is 4.34% as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GPT Healthcare Ltd is engaged in the healthcare sector. It operates a chain of mid-sized full-service hospitals under the ILS brand. It provides integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of approximately 561 beds. It offers a comprehensive range of healthcare services across over 35 specialities and super specialities, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.
45GF Score
Get the complete analysis for NSE:GPTHEALTH
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GPTHEALTH has been successfully added to your 
